Navigation Links
Effectively Bringing Fixed Dose Combination Products to Market to Maintain Growth and Pipelines
Date:3/8/2013

CHAPEL HILL, N.C., March 8, 2013 /PRNewswire/ -- The pharmaceutical industry has turned to sustainable growth opportunities to address the pipeline and patent challenges facing many organizations in the sector. One opportunity for growth lies in extending a product's patent life by combining branded products.

Fixed dose combination (FDC) products have clinical and commercial advantages. For the drug manufacturer, an FDC product can extend the therapeutic advantage and becomes part of lifecycle management. For the patient, FDC products can address unmet medical needs and reduce pill burdens.

But there is more to success than just developing a new FDC and launching it. Successful research and development leaders recognize that understanding the market and audience will smooth the FDC launch process, according to a study by benchmarking leader Best Practices, LLC.

"Fixed Dose Combination Products: Successful Strategies for Developing and Bringing FDC Products to Market" identifies successful strategies and innovative practices for developing and bringing FDC products to market. Through executive insights and advice, the study also addresses the pitfalls and obstacles to avoid in this work.

A third of the FDC leaders who participated in the study said the most important lesson learned from their work with FDC products is the need to focus on the differentiated benefit and value that the product can bring to patients, physicians and payers.

Some of the issues addressed in this research include:

  • Chief reason for pursuing FDC development
  • Measures used to evaluate success
  • Years from decision to develop through launch
  • Cost of FDC product development
  • Time lapsed from initial contact to signed contractual agreement with
    '/>"/>

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ensuring Pharmaceutical Organizations are Effectively Organizing and Deploying Medical Science Liaisons across Diverse Customer Groups
2. Louisiana Pain Specialist Dr. Arnold Feldman Uses Advanced Techniques to Effectively Treat Herniated Disc
3. Effectively Using Communication Channels and Tools to Reach Core Decision Makers in Organizations Across all Business Sectors
4. Positioning Strategies Effectively Minimize Cannibalization of a Legacy Brand When Expanding a Product Portfolio
5. Nutrastar International Completes Multi-Year Production Expansion Project Bringing Cordyceps Capacity to 100 Tons
6. For Drug Manufacturers Bringing a New Product to Market, Gaining the Support of Influential Doctors Is a Mission-Critical Priority
7. Clinical Site Services Is Bringing 3x More Patient Enrollment to the 48th Annual DIA Meeting
8. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
9. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
10. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
11. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  The Mesothelioma Victims Center is incredibly ... get the best possible compensation, and they are also ... rare cancer caused by exposure to asbestos or ... to treatment options such as a recent possible ... Victims Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)... 22, 2015 Research and Markets ... the "Latest Regulations on Pharmaceutical International Multi-Center ... offering. This is first time in ... on international multi-center clinical trials of drugs in ... to be implemented on March 1, 2015. The ...
(Date:5/22/2015)... CITY, Calif. , May 22, 2015 ... pharmaceutical company focused on the development and commercialization of ... pain, today announced that interim chief executive officer ... Healthcare Conference and chief financial officer Tim Morris ... Conference. Details of the two presentations are as follows: ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
... International, Inc. (NYSE: VRX ) (TSX: VRX) today ... live Internet webcast along with a slide presentation on Thursday, ... to discuss results for the 2012 first quarter. ... 876-8393, confirmation code 70937718. International callers should dial (973) ...
... April 16, 2012 To mark World Hemophilia Day 2012, ... financial contributions and donations of clotting factor concentrate to the ... program over the period of three years, beginning in 2012. ... minimum shelf-life of one year. The goal of the WFH ...
Cached Medicine Technology:Valeant Pharmaceuticals to Announce 2012 First Quarter Results on May 3, 2012 2CSL Behring Renews Pledge to Provide Significant Funding and Donated Coagulation Factor to World Federation of Hemophilia Over 3-Year Period 2CSL Behring Renews Pledge to Provide Significant Funding and Donated Coagulation Factor to World Federation of Hemophilia Over 3-Year Period 3
(Date:5/24/2015)... NC (PRWEB) May 24, 2015 Scientists ... a paper on air quality compliance issues that may ... American workers. Surviving Mesothelioma has just posted an article ... now. , The group found airborne asbestos levels ... data collected between 1984 and 2011. , “Asbestos compliance ...
(Date:5/24/2015)... Viejo, CA (PRWEB) May 24, 2015 ProPin ... use in Final Cut Pro X. Utilize ProPin to pin ... in a given scene. , ProPin allows users to ... completely customizable in FCPX. With on-screen controls, video editors can ... allows users to pin and mark with absolute ease. , Using ...
(Date:5/24/2015)... Geneva, WI (PRWEB) May 24, 2015 ... Mercy Health System CEO - ... principal and honored at the fourth ... held April 15 at Geneva National ... (by school): ,     -Badger High School, ...
(Date:5/23/2015)... D.C. (PRWEB) May 23, 2015 On ... of powers of a youngster's yogic power learned through ... Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, a ... more than 50 high profile professionals attending the 2015 ... by reading fluently -- blindfolded. , In a ...
(Date:5/23/2015)... On Wednesday, May 20, 2015, CareFirst ... been the target of a sophisticated cyberattack,” and that ... ongoing Information Technology (IT) security efforts in the wake ... most notable attack on health insurers was reported in ... second largest health insurer, revealed that they had suffered ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... Md., March 11 Iomai Corporation,(Nasdaq: IOMI ) ... chief executive officer, will present at the Cowen and,Company ... March 17.,Mr. Erck,s presentation will begin at 4:45 p.m. ... at 5:30 p.m., The conference will be held ...
... news situation. Some women who have a breast biopsy ... do have atypical hyperplasia -- cells that arent quite ... one-fourth of women undergoing breast biopsies but no one ... quest to discover who is at risk, researchers at ...
... The Saada Foundation announced a gift,of $5 million ... Door",capital campaign. This is the largest philanthropic gift received ... $3 million from The Hersh,Foundation and $2.5 million from ... other major donors, the campaign now reaches $14 million ...
... that profiles molecular biomarkers in blood could become the first ... The screen relies on changes in dozens of small molecules ... people with Parkinson,s disease, according to a team led by ... City. , They published the findings in the journal Brain. ...
... blockers, other meds also increases odds, study finds ... diagnosed and treated for glaucoma and those with high ... for cardiovascular death, a new study suggests. , "Glaucoma ... worldwide," the researchers from Stony Brook University in Stony ...
... standard infection control was just as effective ... screening for a common antibiotic-resistant bacteria is no ... rate of hospital-acquired infections in surgical patients, new ... Staphylococcus aureus (MRSA), is an increasing public ...
Cached Medicine News:Health News:Iomai CEO to Speak at Cowen and Company Health Care Conference on Monday, March 17 2Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 2Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 3Health News:COX-2 expression is marker for cancer development in some benign breast biopsies 4Health News:St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift 2Health News:First early-detection blood test for Parkinson's shows promise 2Health News:First early-detection blood test for Parkinson's shows promise 3Health News:Glaucoma May Boost Cardiovascular Death Risk in Blacks 2Health News:Universal Screening for MRSA in Hospitals Made Little Difference 2Health News:Universal Screening for MRSA in Hospitals Made Little Difference 3
Synchron CX3 Delta is a critical care clinical system, providing unparalleled testing speed for the most frequently ordered chemistries-Glucose, BUN, Creatinine, Sodium, Potassium Chloride, CO2 Calci...
Iron (Total/Ferene). Storage temp: 15 - 30 C. Linearity: 0 - 500 ug/dl. Expected values: from males 60 - 160 ug/dl, from females 43 - 140 ug/dl. Available with Calibrator and Number of test are 120....
For the quantitative determination of iron, total iron-binding capacity in human serum....
HDL Cholesterol, liquid....
Medicine Products: